fda_approval · anda · info
SCIEGEN PHARMS — ANDA approval: BRIVARACETAM (unspecified)
- Event date
- 2026-07-01 00:00:00Z
- Observed
- 2026-07-09 22:53:29Z
- Source ID
- ANDA219952-1
- Payload hash
- a73eba209eb0bfd3ec0a2244…
Summary
SCIEGEN PHARMS received ANDA approval for BRIVARACETAM (unspecified) on 2026-07-01. Dosage form: TABLET. Application #: ANDA219952.
Entities
Informational only. Not legal, financial, or medical advice.